US EditionFDA warns California company about selling injectable CBD
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
FDA warns California company about selling injectable CBD
The U.S. Food and Drug Administration last week sent a warning letter to a California manufacturer that has been marketing an injectable hemp CBD product to medical patients. The letter, dated March 6, was sent to Sacramento-based Pico IV and asserts that its “intravenous form of cannabidiol” is an “unapproved new... Please login to read all 313 words.
A startup is selling injectable cannabis. The FDA isn't happy
*This article first appeared on SFGate.com and is reposted with permission The Food and Drug Administration warned a California cannabis company on Monday that its injectable hemp CBD could be posing “serious harm” to public health, telling the company that its product is violating federal law. Pico IV sells a purified version of CBD, a non-intoxicating compound produced by cannabis, that is designed to be injected into the bloodstream through …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
